Searched for
EFFICACY DATA
India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- How an Australian connection helped Shaily Mehrotra build a Rs 1,500-crore Indian skincare brandA gap in science-backed skincare products in the Indian market prompted Shaily Mehrotra to start Fixderma, with an aim to solve common skin...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- Google blocked the first known AI-powered attack on 2FA accounts; here is how hackers tried to break in, know how to stay safeForeign hackers attempted a novel AI-powered cyberattack targeting two-factor authentication using a zero-day exploit. Google's Threat Inte...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Why More Car Owners Are Putting Their Keys in Aluminum Foil to Prevent Silent Thefts That Take SecondsModern car thieves are exploiting keyless entry systems through relay attacks, where signals from key fobs are intercepted and amplified to...
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- I-Beauty! After J, K and C, now it's India's turn in the big beautiful marketIndia's beauty industry is emerging as a global force, blending Ayurvedic heritage with modern science to create "I-beauty." With rising ex...
- The 2013 ghost returns: Will higher gold duties actually restrict imports or just fuel the grey market?India’s shock hike in gold and silver import duty to 15% has revived memories of the 2013 crisis. While the move aims to curb dollar outflo...
- Emami to buy 60% stake in SkinKraft, Vedix parent IncNut for Rs 321 croreKolkata's Emami is set to acquire a significant 60% stake in IncNut Digital. This company is the driving force behind popular beauty brands...
- Govt awarded 172 oil & gas blocks in 10 years, but negligible output brings policy and execution into focusIndia's ambitious oil and gas policy has failed to boost domestic production. Despite billions invested and extensive exploration, only one...
Load More
